GAO: Specialty drugs accounted for 10% of Medicare Part D spending in 2007 Abbott, Enanta hope hepatitis C drug will boost market FDA committee recommends kidney transplant drug be approved FDA, EMEA adopt orphan drug report system Merck buys Millipore FDA accepts regulatory application for Qnexa Regulus, GSK develop hepatitis C therapies FDA approves Shire's Type 1 Gaucher disease Bioscrip reports losses in 2009 Study finds bitter melon may reduce breast cancer risk First Previous 208 209 210 211 212 Next Last